FDA
-
-
-
-
-
-
-
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
-
-
-
-
-
-
-
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
-
-
-
-
-
-
-
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2020 Financial Results
-
-
-
-
-
-
-
Waters Corporation (NYSE: WAT) Reports Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Pre-Open Movers 04/24: (EVLV) (SANM) (WFT) Higher; (EPZM) (WAT) (MMM) Lower (more...)
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

